Skip to content

Ventas VTR OM&R — Number of real estate properties

Other segment segments

NNN
10
SHOP
1-88.9%

Similar metrics at other companies

Welltower logo
WELLOutpatient Medical — Number of real estate properties
4
CubeSmart logo
CUBEOR — Number Of Real Estate Properties
10.0%
Welltower logo
WELLOutpatient Medical — No. of Properties
20.3
Dime Community Bancshares
 logo
DCOMNumber Of Real Estate Properties
1-50.0%
EFC
EFCNumber Of Real Estate Properties
199+47.4%
Healthpeak Properties logo
DOCOutpatient Medical Buildings — Property count
59+5,800%

Other financials

Income statement

See full
Revenue$1.7B+22.0%
Net income$59.0M+22.1%
EPS (diluted)$0.11+10.0%

Balance sheet

See full
Cash & equivalents$183.6M+0.7%
Total debt$12.7B-1.5%
Total equity$13.1B+14.4%
Total assets$27.7B+6.4%

Cash flow

See full
Operating cash flow$394.6M+22.9%

Valuation

See full
Market cap$42.51B+50.8%
Enterprise value$55.05B+34.5%
P/E156.2×-32.7×
P/S6.9×+1.4×

Profitability

See full
Net margin4.4%+1.5pp
FCF margin33.1%

Returns & leverage

See full
Return on equity2.2%+0.8pp
Debt / equity-0.2×

Where this comes from

Reported directly by Ventas in its filing.

Tagged under the XBRL concept us-gaap:NumberOfRealEstateProperties.

The official record: Ventas’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ventas's om&r — number of real estate properties.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ventas's OM&R — number of real estate properties?
Ventas (VTR) reported OM&R — number of real estate properties of 1 in Q1 2026.
How has Ventas's OM&R — number of real estate properties changed year-over-year?
Ventas's OM&R — number of real estate properties decreased by 94.7% year-over-year, from 19 to 1.
What does OM&R — number of real estate properties mean?
The total count of individual real estate assets classified within the Outpatient Medical and Research portfolio. This metric tracks the physical scale and footprint of the company's medical office and life science holdings. It provides insight into the company's growth through acquisitions or divestitures within this specific segment.